vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and RCM TECHNOLOGIES, INC. (RCMT). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $86.5M, roughly 1.7× RCM TECHNOLOGIES, INC.). RCM TECHNOLOGIES, INC. runs the higher net margin — 7.1% vs -21.1%, a 28.1% gap on every dollar of revenue. On growth, RCM TECHNOLOGIES, INC. posted the faster year-over-year revenue change (12.4% vs -19.2%). Over the past eight quarters, RCM TECHNOLOGIES, INC.'s revenue compounded faster (9.6% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Exela Technologies, Inc. is an American business process automation ("BPA") company. It was created with the merger of SourceHOV LCC, Novitex Holdings, Inc. and Quinpario Acquisition Corp. 2.

OPK vs RCMT — Head-to-Head

Bigger by revenue
OPK
OPK
1.7× larger
OPK
$148.5M
$86.5M
RCMT
Growing faster (revenue YoY)
RCMT
RCMT
+31.6% gap
RCMT
12.4%
-19.2%
OPK
Higher net margin
RCMT
RCMT
28.1% more per $
RCMT
7.1%
-21.1%
OPK
Faster 2-yr revenue CAGR
RCMT
RCMT
Annualised
RCMT
9.6%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OPK
OPK
RCMT
RCMT
Revenue
$148.5M
$86.5M
Net Profit
$-31.3M
$6.1M
Gross Margin
43.1%
28.1%
Operating Margin
-25.8%
9.2%
Net Margin
-21.1%
7.1%
Revenue YoY
-19.2%
12.4%
Net Profit YoY
-322.8%
112.9%
EPS (diluted)
$-0.04
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
RCMT
RCMT
Q1 26
$86.5M
Q4 25
$148.5M
Q3 25
$151.7M
$70.3M
Q2 25
$156.8M
$78.2M
Q1 25
$150.0M
$84.5M
Q4 24
$183.6M
$76.9M
Q3 24
$173.6M
$60.4M
Q2 24
$182.2M
$69.2M
Net Profit
OPK
OPK
RCMT
RCMT
Q1 26
$6.1M
Q4 25
$-31.3M
Q3 25
$21.6M
$2.3M
Q2 25
$-148.4M
$3.8M
Q1 25
$-67.6M
$4.2M
Q4 24
$14.0M
$2.9M
Q3 24
$24.9M
$2.7M
Q2 24
$-10.3M
$3.8M
Gross Margin
OPK
OPK
RCMT
RCMT
Q1 26
28.1%
Q4 25
43.1%
Q3 25
32.9%
27.6%
Q2 25
31.5%
28.5%
Q1 25
28.4%
26.0%
Q4 24
46.1%
28.0%
Q3 24
23.1%
29.6%
Q2 24
28.4%
28.9%
Operating Margin
OPK
OPK
RCMT
RCMT
Q1 26
9.2%
Q4 25
-25.8%
Q3 25
31.7%
5.6%
Q2 25
-38.3%
8.4%
Q1 25
-44.8%
7.8%
Q4 24
-18.0%
8.2%
Q3 24
8.2%
7.3%
Q2 24
-33.9%
8.4%
Net Margin
OPK
OPK
RCMT
RCMT
Q1 26
7.1%
Q4 25
-21.1%
Q3 25
14.3%
3.2%
Q2 25
-94.7%
4.8%
Q1 25
-45.1%
5.0%
Q4 24
7.6%
3.7%
Q3 24
14.3%
4.5%
Q2 24
-5.7%
5.4%
EPS (diluted)
OPK
OPK
RCMT
RCMT
Q1 26
$0.80
Q4 25
$-0.04
Q3 25
$0.03
$0.30
Q2 25
$-0.19
$0.50
Q1 25
$-0.10
$0.54
Q4 24
$0.02
$0.38
Q3 24
$0.03
$0.35
Q2 24
$-0.01
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
RCMT
RCMT
Cash + ST InvestmentsLiquidity on hand
$364.4M
$2.9M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$46.0M
Total Assets
$1.9B
$134.4M
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
RCMT
RCMT
Q1 26
$2.9M
Q4 25
$364.4M
Q3 25
$412.0M
$1.3M
Q2 25
$267.3M
$5.5M
Q1 25
$428.8M
$5.2M
Q4 24
$426.6M
$4.7M
Q3 24
$400.1M
$3.2M
Q2 24
$40.6M
$3.5M
Total Debt
OPK
OPK
RCMT
RCMT
Q1 26
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Stockholders' Equity
OPK
OPK
RCMT
RCMT
Q1 26
$46.0M
Q4 25
$1.3B
Q3 25
$1.3B
$41.4M
Q2 25
$1.3B
$37.8M
Q1 25
$1.3B
$34.6M
Q4 24
$1.4B
$33.5M
Q3 24
$1.4B
$30.0M
Q2 24
$1.4B
$28.5M
Total Assets
OPK
OPK
RCMT
RCMT
Q1 26
$134.4M
Q4 25
$1.9B
Q3 25
$2.0B
$129.8M
Q2 25
$2.0B
$135.6M
Q1 25
$2.1B
$121.0M
Q4 24
$2.2B
$132.1M
Q3 24
$2.3B
$125.5M
Q2 24
$2.0B
$118.3M
Debt / Equity
OPK
OPK
RCMT
RCMT
Q1 26
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
RCMT
RCMT
Operating Cash FlowLast quarter
$-25.9M
$19.0M
Free Cash FlowOCF − Capex
$-28.6M
FCF MarginFCF / Revenue
-19.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
3.11×
TTM Free Cash FlowTrailing 4 quarters
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
RCMT
RCMT
Q1 26
$19.0M
Q4 25
$-25.9M
Q3 25
$-34.6M
$-1.3M
Q2 25
$-83.4M
$-7.9M
Q1 25
$-34.6M
$16.7M
Q4 24
$-44.4M
$-1.6M
Q3 24
$-77.1M
$-4.3M
Q2 24
$-26.4M
$5.7M
Free Cash Flow
OPK
OPK
RCMT
RCMT
Q1 26
Q4 25
$-28.6M
Q3 25
$-37.8M
$-1.8M
Q2 25
$-86.7M
$-8.4M
Q1 25
$-37.7M
$16.2M
Q4 24
$-49.8M
$-2.6M
Q3 24
$-85.0M
$-4.9M
Q2 24
$-33.7M
$5.3M
FCF Margin
OPK
OPK
RCMT
RCMT
Q1 26
Q4 25
-19.3%
Q3 25
-24.9%
-2.5%
Q2 25
-55.3%
-10.7%
Q1 25
-25.2%
19.2%
Q4 24
-27.1%
-3.4%
Q3 24
-49.0%
-8.1%
Q2 24
-18.5%
7.7%
Capex Intensity
OPK
OPK
RCMT
RCMT
Q1 26
Q4 25
1.8%
Q3 25
2.1%
0.7%
Q2 25
2.1%
0.6%
Q1 25
2.1%
0.5%
Q4 24
2.9%
1.3%
Q3 24
4.6%
0.9%
Q2 24
4.0%
0.6%
Cash Conversion
OPK
OPK
RCMT
RCMT
Q1 26
3.11×
Q4 25
Q3 25
-1.60×
-0.56×
Q2 25
-2.08×
Q1 25
3.98×
Q4 24
-3.17×
-0.57×
Q3 24
-3.10×
-1.58×
Q2 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

RCMT
RCMT

Segment breakdown not available.

Related Comparisons